THE ADVANTAGE OF
CLINICALLY PROVEN INFORMATION
The Prolaris® test from Myriad Genetics, the world’s leader in genetic testing, adds clinically proven information to traditional diagnostic tools like PSA and Gleason and spells out how fast your prostate cancer will progress. The Prolaris test helps you avoid overly aggressive treatments – or those that aren’t aggressive enough.
For Patients and Caregivers
After a prostate cancer diagnosis, choosing an appropriate treatment plan can be incredibly stressful for you and your loved ones. The Prolaris test clarifies your cancer risk, allowing your doctor to create a customized treatment or active surveillance plan.
The decision to treat or not can be complicated. The Prolaris test adds clinically proven information to traditional diagnostic tools and spells out how quickly a patient’s prostate cancer will progress. The Prolaris test helps you present truly informed treatment options to your patient – providing you both confidence in your decisions.
Myriad Hereditary Cancer Test
Up to 1 in 6 men with prostate cancer have a genetic mutation that may have caused their cancer. If you have a mutation, your sons, daughters and siblings all have a 50% chance of having the same gene mutation. Hereditary cancer testing is the only way to identify this risk.
Decide What Is Right For You
Prolaris is an in-depth assessment of a patient’s prostate cancer aggressiveness. It is the only test that measures how fast a prostate cancer tumor is growing. Whether you are a patient or caregiver, or a physician, we have additional information to help you make the most informed decision possible.